The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type

Table 4 Univariable and multivariable analyses of Academic vs. Non-academic stratified by primary cancer site

Tumor type	Univariable HR (95% CI)	P	Multivariable HR (95% CI)	P
Tumor type	Academic centers vs. non-academic centers	P	Academic centers vs. non-academic centers	P
Breast cancer	0.838 (0.778–0.902)	0.001	0.848 (0.785–0.916)	0.001
NSCL	0.812 (0.798–0.827)	0.001	0.854 (0.838–0.869)	0.001
SCLC	0.876 (0.844–0.909)	0.001	0.902 (0.868–0.937)	0.001
Other types of lung cancer	0.784 (0.740–0.830)	0.001	0.846 (0.796–0.898)	0.001
Melanoma	0.733 (0.678–0.794)	0.001	0.781 (0.719–0.847)	0.001
Colon cancer	0.907 (0.796–1.033)	0.14	0.945 (0.822–1.086)	0.42
Kidney cancer	0.761 (0.700–0.827)	0.001	0.803 (0.736–0.876)	0.001

Multivariable analyses were adjusted for age at diagnosis, sex, race, health insurance status, income level, education level, place of living, comorbidity score, chemotherapy, radiation therapy, immunotherapy, surgery to the primary cancer site, and year of diagnosis

ISSN: 1471-2407